Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Lin Fan, Yuanyuan Zhang, Peter Maguire, Dominic Muston, Matthew Monberg, Jagadeswara Rao Earla, Adela Mihai & Poonam Gulati. (2022) Cost comparison of adverse event management among breast and ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors: analysis based on phase 3 clinical trials. Journal of Market Access & Health Policy 10:1.
Read now
Read now
Beiwen Ni & Jian Hou. (2022) Promising therapeutic approaches for relapsed/refractory multiple myeloma. Hematology 27:1, pages 343-352.
Read now
Read now
A. M. U. B. Mahfuz, Felipe Stambuk Opazo, Luis F. Aguilar & Muhammad Nasir Iqbal. (2022) Carfilzomib as a potential inhibitor of NADH-dependent enoyl-acyl carrier protein reductases of Klebsiella pneumoniae and Mycobacterium tuberculosis as a drug target enzyme: insights from molecular docking and molecular dynamics. Journal of Biomolecular Structure and Dynamics 40:9, pages 4021-4037.
Read now
Read now
Paul G Richardson, Shaji Kumar, Jacob P Laubach, Claudia Paba-Prada, Neeraj Gupta, Deborah Berg, Helgi van de Velde & Philippe Moreau. (2017) New developments in the management of relapsed/refractory multiple myeloma – the role of ixazomib. Journal of Blood Medicine 8, pages 107-121.
Read now
Read now
Faisal Imam, Naif O. Al-Harbi, Mohammad Matar Al-Harbi, Mushtaq Ahmad Ansari, Mashal M Almutairi, Musaad Alshammari, Talal Saad Almukhlafi, Mohd Nazam Ansari, Khaldoon Aljerian & Sheikh Fayaz Ahmad. (2016) Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats. Toxicology Mechanisms and Methods 26:9, pages 700-708.
Read now
Read now
Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis & Meletios A. Dimopoulos. (2016) Current treatments for renal failure due to multiple myeloma. Expert Opinion on Pharmacotherapy 17:16, pages 2165-2177.
Read now
Read now
Despoina Fotiou, Meletios A. Dimopoulos & Efstathios Kastritis. (2016) Managing renal complications in multiple myeloma. Expert Review of Hematology 9:9, pages 839-850.
Read now
Read now
Articles from other publishers (6)
Farhan Azad, Ross Moyer, Clive J Miranda & Matthew Gravina. (2023) Carfilzomib-Induced Tumor Lysis Syndrome and Biventricular Heart Failure in a Patient With Multiple Myeloma. Cureus.
Crossref
Crossref
Ekaterina Proskuriakova, Keji Jada, Sandrine Kakieu Djossi, Anwar Khedr, Bandana Neupane & Jihan A Mostafa. (2021) Mechanisms and Potential Treatment Options of Heart Failure in Patients With Multiple Myeloma. Cureus.
Crossref
Crossref
Asma M. Al-Jasser & Khalid Ahmed Al-Anazi. 2019. Update on Multiple Myeloma. Update on Multiple Myeloma.
Huamao Mark Lin, Keith L. Davis, James A. Kaye, Katarina Luptakova, Saurabh P. Nagar & Mohamad Mohty. (2019) Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France. Advances in Hematology 2019, pages 1-12.
Crossref
Crossref
Kristen B. McCullough, Miriam A. Hobbs, Jithma P. Abeykoon & Prashant Kapoor. (2018) Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies. Current Hematologic Malignancy Reports 13:2, pages 114-124.
Crossref
Crossref
Monika Engelhardt, Magdalena Szymaniak-Vits, Stefanie Ajayi, Sandra Maria Dold, Stefan Jürgen Müller, Sophia Scheubeck & Ralph Wäsch. 2018. Small Molecules in Hematology. Small Molecules in Hematology
265
283
.